GOSS Earnings — Gossamer Bio, Inc. Common Stock Post-ER Performance | BigEarnings
GOSS — Gossamer Bio, Inc. Common Stock
XNAS · Healthcare · Biotechnology
Price$0.17
Market Cap$82.6M
P/E—
52W Range$0.14 – $3.87
Next Earnings2026-08-04
About Gossamer Bio, Inc. Common Stock
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
